It can develop at any age and is influenced by a combination of factors including genetics, facial structure, hormone changes, and fat distribution patterns
This stems from altered enterohepatic circulationwithout a gallbladder, bile flows continuously rather than in controlled pulses, amplifying GLP-1's effects on intestinal transit
The Next-generation Obesity Drug Pipeline market was dominated by North America region in 2025 fueled by a robust healthcare system and a high rate of obesity
Compounded medications discussed here are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing
We suggest
Qi L, Gao R, Chen Z, Lin D, Liu Z, Wang L, et al